Currently trading at less than $1, the shares of China-based BIMI International Medical’s (BIMI) have dipped 72.2% in price over the past year. So, given the company’s weak financials and poor profitability, will its stock be able to regain its momentum? Continue reading to learn more. Headquartered China-based, BIMI International Medical Inc. offers medical equipment, pharmaceuticals, as well as other healthcare products, to both consumers and wholesalers. Lijiantang Pharmacy is the brand used by this company. It also offers IT research and development.

BIMI’s stock has tanked 53.5% in price over the past year and 24.3% over the past three months to close yesterday’s trading session at $0.78. It currently trades 72.2% lower than its 52-week highest of $2.81. This high was set on February 10, 20,21.

Despite global growth in healthcare, BIMI’s trailing twelve months of losses has been disappointing. Although the stock has a solid foothold in healthcare markets through strategic alliances as well as a variety of service and product offerings, it could see a decline in its financial performance and profitability in the short term.

Continue reading on StockNews